Compare Stocks
Compare up to 5 stocks side by side with metrics, growth rates, and performance charts
Select Stocks
CTKB
FTH
Add up to 3 more stocks
CTKB
Cytek Biosciences, Inc.
-8.76%
$5.56-0.53Delayed quote: Oct 6, 2026, 1:10 PM EDT
Market Cap
$717.57M
52W Range
$3.31 - $6.18
FTH
Faeth Therapeutics, Inc.
+5.61%
$28.62+1.52Delayed quote: Oct 6, 2026, 1:10 PM EDT
Market Cap
$737.79M
52W Range
$7.45 - $42.14
| Metric | ||
|---|---|---|
| ValuationTTM multiples, at last close | ||
| P/E Ratio | N/A | N/A |
| Forward P/E | N/A | N/A |
| PEG Ratio | N/A | N/A |
| P/B Ratio | 2.23 | 4.27 |
| P/S Ratio | 3.47 | N/A |
| P/FCF Ratio | N/A | N/A |
| EV/EBITDA | N/A | N/A |
| Profitabilitytrailing twelve months | ||
| Gross Margin | 53.2% | 0.0% |
| Operating Margin | -21.6% | 0.0% |
| Net Margin | -39.0% | 0.0% |
| ROE | -25.0% | -113.0% |
| ROA | -18.0% | -103.3% |
| ROIC | -12.0% | -110.6% |
| Financial Healthlatest reported quarter | ||
| Current Ratio | 4.48 | 19.69 |
| Quick Ratio | 3.86 | 19.69 |
| Debt/Equity | 0.08 | 0.00 |
| Interest Coverage | -85.20 | -696.50 |
| Dividendstrailing dividends vs latest price | ||
| Dividend Yield | N/A | N/A |
| Payout Ratio | N/A | N/A |
| Yrs of Dividend Growth | 0 | 0 |
N/A includes missing data and metrics withheld while their applicability to the company is unverified. Bars show each value's size relative to the row's largest — a factual magnitude cue, not a rating. Tap a metric name for its full history.